ANDREW BURNS: Open Payments
NPI 1487806006 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,410 in 204 payments from 19 companies in 2025. Trend: 2023 $2,610 · 2024 $2,117 · 2025 $2,410
Food & beverage: $2,410
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 35 | $340 |
| MAYNE PHARMA COMMERCIAL LLC | 36 | $338 |
| ABBVIE INC. | 23 | $221 |
| Novartis Pharmaceuticals Corporation | 19 | $212 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 12 | $173 |
| Incyte Corporation | 13 | $173 |
| UCB, Inc. | 19 | $169 |
| Janssen Biotech, Inc. | 13 | $144 |
| Almirall LLC | 7 | $135 |
| Lilly USA, LLC | 5 | $117 |
Products named: AKLIEF, SKYRIZI, OPZELURA, Bimzelx, TREMFYA, Klisyri, TALTZ, Winlevi.
Industry payments across IN — which companies pay providers there.
